Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential Hypertension

ClinicalTrials.gov ID: NCT00591578

Public ClinicalTrials.gov record NCT00591578. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 16, 2026, 10:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Parallel-Group Study to Compare the Efficacy and Safety of TAK-491 With Valsartan in Subjects With Essential Hypertension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the efficacy and safety of TAK-491 (azilsartan medoxomil), once daily (QD), to valsartan in participants with essential hypertension.

Study identification

NCT ID
NCT00591578
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Takeda
Industry
Enrollment
984 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2007 (Type not available)
Primary completion
Sep 2009 (Actual)
Completion
Mar 2010 (Actual)
Last update posted
Feb 2, 2012

2007 – 2010

United States locations

U.S. sites
77
U.S. states
27
U.S. cities
77
Facility City State ZIP Site status
Not listed Huntsville Alabama — —
Not listed Glendale Arizona — —
Not listed Phoenix Arizona — —
Not listed Scottsdale Arizona — —
Not listed Tuscon Arizona — —
Not listed Beverly Hills California — —
Not listed Burbank California — —
Not listed La Jolla California — —
Not listed Long Beach California — —
Not listed Los Angeles California — —
Not listed Paramount California — —
Not listed San Diego California — —
Not listed Santa Monica California — —
Not listed Spring Valley California — —
Not listed Tustin California — —
Not listed Vista California — —
Not listed Westlake Village California — —
Not listed Ridgefield Connecticut — —
Not listed Newark Delaware — —
Not listed Washington D.C. District of Columbia — —
Not listed DeLand Florida — —
Not listed Fort Lauderdale Florida — —
Not listed Hollywood Florida — —
Not listed Inverness Florida — —
Not listed Jacksonville Florida — —
Not listed Boise Idaho — —
Not listed Chicago Illinois — —
Not listed Gurnee Illinois — —
Not listed Morton Illinois — —
Not listed Park Ridge Illinois — —
Not listed Avon Indiana — —
Not listed Bloomington Indiana — —
Not listed Crestview Hills Kentucky — —
Not listed Baltimore Maryland — —
Not listed Columbia Maryland — —
Not listed Brockton Massachusetts — —
Not listed West Yarmouth Massachusetts — —
Not listed Ann Arbor Michigan — —
Not listed City of Saint Peters Missouri — —
Not listed Florissant Missouri — —
Not listed Kansas City Missouri — —
Not listed Washington Missouri — —
Not listed Wentzville Missouri — —
Not listed Charlotte North Carolina — —
Not listed Salisbury North Carolina — —
Not listed Shelby North Carolina — —
Not listed Cincinnati Ohio — —
Not listed Delaware Ohio — —
Not listed Mogadore Ohio — —
Not listed Willoughby Hills Ohio — —
Not listed Zanesville Ohio — —
Not listed Oklahoma City Oklahoma — —
Not listed Eugene Oregon — —
Not listed Portland Oregon — —
Not listed Bridgeville Pennsylvania — —
Not listed Downingtown Pennsylvania — —
Not listed Jenkintown Pennsylvania — —
Not listed Lansdale Pennsylvania — —
Not listed Charleston South Carolina — —
Not listed Spartanburg South Carolina — —
Not listed Kingsport Tennessee — —
Not listed Austin Texas — —
Not listed Dallas Texas — —
Not listed Fort Worth Texas — —
Not listed Houston Texas — —
Not listed Pearland Texas — —
Not listed Rosenberg Texas — —
Not listed San Antonio Texas — —
Not listed Riverton Utah — —
Not listed Salt Lake City Utah — —
Not listed West Jordan Utah — —
Not listed Arlington Virginia — —
Not listed Burke Virginia — —
Not listed Norfolk Virginia — —
Not listed Lakewood Washington — —
Not listed Port Richard Washington — —
Not listed Menomonee Falls Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00591578, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 2, 2012 · Synced Oct 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00591578 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →